Form 4 for BDX Becton Dickinson
Accepted 2024-11-29 00:00:00 ET · period of report 2024-11-26 · accession 0001062993-24-019798 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-29 | 2024-11-26 | BDX | Feld Michael | EVP, Pres, Life Sciences | A - Grant | $0.00 | +2,553 | 9,190 | +38% | $0 |
| D | 2024-11-29 | 2024-11-26 | BDX | Feld Michael | EVP, Pres, Life Sciences | A - Grant | $0.00 | +10.0K | 10.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-26 | A | A | 2,553 | $0.00 | 9,190 | D | — | — | (F1) Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. |
| 2 | Derivative | Stock Appreciated Rights | 2024-11-26 | A | A | 10,004 | $0.00 | 10,004 | D | $224.25 · 2025-11-26 to 2034-11-26 | 10,004 Common Stock | (F2) The stock appreciation rights vest in four annual installments beginning November 26, 2025. |